Daniel Char - 19 Jul 2022 Form 4 Insider Report for Evelo Biosciences, Inc.

Role
General Counsel
Signature
/s/ Daniel S. Char
Issuer symbol
EVLO on OTC
Transactions as of
19 Jul 2022
Net transactions value
$0
Form type
4
Filing time
14 Oct 2022, 16:37:38 UTC
Previous filing
21 Jan 2022
Next filing
30 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 19 Jul 2022 Common Stock 40,000 $2.24 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option will vest as to 50% of the underlying shares on the first anniversary of the date of grant, and as to the remaining 50% of the underlying shares on the second anniversary of the date of grant.